Prof Benjamin Land

Experts / Prof Benjamin Land

Prof Benjamin Land

Research Assistant Professor of Pharmacology; School of Medicine, University of Washington

Prof Land’s lab is interested in the intersection of opioids and cannabinoids in the context of pain management and substance use disorder. Specifically, he’s interested in how cannabinoids may or may not be used to treat chronic pain in conjunction with opioids, and the associated addiction risk.

They use whole animal pharmacology, viral methods, modern imaging techniques, and biochemical approaches.

Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how

Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market

Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how

Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market

By Prof Benjamin Land

Clinical Articles

Addiction medicine, Drugs and devices

Prof Benjamin Land

Research Assistant Professor of Pharmacology; School of Medicine, University of Washington

More from this expert

Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how

Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market

Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how

Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Prof Benjamin Land

Research Assistant Professor of Pharmacology; School of Medicine, University of Washington

More from this expert

Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how

Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market

Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how

Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.